⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL132 | 1.00 | — | — | |
| SCHEMBL4264805 | 1.00 | TSHR (0.50) | — | |
| SCHEMBL2364171 | 0.96 | TSHR (0.46) | — | |
| SCHEMBL20636758 | 0.96 | — | — | |
| SCHEMBL4624152 | 0.96 | — | — | |
| SCHEMBL23451643 | 0.96 | — | — | |
| SCHEMBL12500497 | 0.96 | — | — | |
| SCHEMBL2541301 | 0.96 | — | — | |
| SCHEMBL23045803 | 0.96 | — | — | |
| SCHEMBL11025508 | 0.96 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2922575-A1 | TRIOXACARCINS, TRIOXACARCIN-ANTIBODY CONJUGATES, AND USES THEREOF | President and Fellows of Harvard College (US) | 2015-09-30 | — | — | EP | claimed |
| WO-2014082065-A1 | TRIOXACARCINS, TRIOXACARCIN-ANTIBODY CONJUGATES, AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2014-05-30 | — | — | WO | claimed |
| US-10982174-B2 | Synergistic surfactant blends | STEPAN COMPANY (US) | 2021-04-20 | — | — | US | disclosed |
| US-20200040279-A1 | SYNERGISTIC SURFACTANT BLENDS | STEPAN CO (US) | 2020-02-06 | — | — | US | disclosed |
| EP-2632893-B1 | ESTERAMINES AND DERIVATIVES FROM NATURAL OIL METATHESIS | STEPAN CO (US) | 2018-12-05 | — | — | EP | disclosed |
| US-9796662-B2 | Esteramines and derivatives from natural oil metathesis | STEPAN COMPANY (US) | 2017-10-24 | — | — | US | disclosed |
| US-20170211016-A1 | SYNERGISTIC SURFACTANT BLENDS | STEPAN CO (US) | 2017-07-27 | — | — | US | disclosed |
| US-9688944-B2 | Synergistic surfactant blends | STEPAN COMPANY (US) | 2017-06-27 | — | — | US | disclosed |
| US-20160023989-A1 | ESTERAMINES AND DERIVATIVES FROM NATURAL OIL METATHESIS | STEPAN CO (US) | 2016-01-28 | — | — | US | disclosed |
| US-9187711-B2 | Esteramines and derivatives from natural oil metathesis | STEPAN COMPANY (US) | 2015-11-17 | — | — | US | disclosed |
| EP-2922575-A1 | TRIOXACARCINS, TRIOXACARCIN-ANTIBODY CONJUGATES, AND USES THEREOF | President and Fellows of Harvard College (US) | 2015-09-30 | — | — | EP | disclosed |
| US-20150094383-A1 | SYNERGISTIC SURFACTANT BLENDS | STEPAN CO (US) | 2015-04-02 | — | — | US | disclosed |
| WO-2014082065-A1 | TRIOXACARCINS, TRIOXACARCIN-ANTIBODY CONJUGATES, AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2014-05-30 | — | — | WO | disclosed |
| WO-2013162924-A1 | SYNERGISTIC SURFACTANT BLENDS | STEPAN COMPANY (US) | 2013-10-31 | — | — | WO | disclosed |
| EP-2632893-A1 | ESTERAMINES AND DERIVATIVES FROM NATURAL OIL METATHESIS | Stepan Company (US) | 2013-09-04 | — | — | EP | disclosed |
| US-20130225859-A1 | ESTERAMINES AND DERIVATIVES FROM NATURAL OIL METATHESIS | STEPAN COMPANY (US) | 2013-08-29 | — | — | US | disclosed |
| WO-2012061093-A1 | ESTERAMINES AND DERIVATIVES FROM NATURAL OIL METATHESIS | STEPAN COMPANY (US) | 2012-05-10 | — | — | WO | disclosed |